Actively Recruiting
Reconsidering Severity Classification for Binge Eating Disorder (BED): the Role of Impulsivity, Compulsivity and Co-occurring Disorders
Led by Laval University · Updated on 2024-10-09
200
Participants Needed
2
Research Sites
13 weeks
Total Duration
On this page
Sponsors
L
Laval University
Lead Sponsor
I
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are investigating Binge Eating Disorder (BED) in adults with obesity to better understand its severity and related health conditions. This study focuses on how impulsivity, compulsivity, emotional regulation, attention problems, and other co-occurring disorders may distinguish more severe BED cases from milder ones. Improved severity classification aims to help in screening and managing BED more effectively. This observational study includes two groups: adults with obesity and BED, and adults with obesity but without BED. Obesity is defined as a body mass index (BMI) of 30 or higher. Participants with BED are identified by a positive Binge Eating Disorder Screener (BEDS)-7 score and a Binge Eating Scale score above 16, while the control group has negative BEDS-7 scores and Binge Eating Scale scores below 12. No treatments are given as part of the study. Participants will undergo assessments including physical and psychological evaluations, body measurements, blood tests, and various questionnaires and cognitive tests related to impulsivity, compulsivity, emotion regulation, anxiety, attention, and depression. The main outcomes include measuring physical and psychological comorbidities and the severity of binge eating. The study is led by Laval University and runs through 2025 with participants aged 18 to 65 years.
CONDITIONS
Brief Title
Compuls-BED-Severity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men or women aged between 18 and 65 years
- Eligible for bariatric surgery (BMI >40, or BMI >35 with severe comorbidities)
- Scheduled for medical evaluation and treatment of obesity at the IUCPQ Obesity Clinic with BMI 630
- Scheduled for evaluation and treatment of BED at the CEPIA with obesity (BMI 630)
- For BED group: positive BEDS-7 screen and Binge Eating Scale score >16
- For control group: negative BEDS-7 screen and Binge Eating Scale score <12
- Fluent in French and able to consent
You will not qualify if you...
- Severe neurological disorder and/or major neurocognitive deficits
- Previous bariatric surgery or changes in anti-obesity medication (liraglutide or naltrexone/bupropion) in the last 3 months
- Cannot read or understand French
- Under guardianship or curatorship
- Already included in a conflicting study
- Unable to use a computer or iPad
- Unable to access Internet or attend inclusion sites
- Discordance between BEDS-7 and Binge Eating Scale results
- Did not complete assessments or missing data rate >10%
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 to 2 weeks
Participants undergo assessments including physical measurements, psychological scales, and cognitive tasks to evaluate binge eating disorder severity and related factors.
1 to 2 visits depending on assessments
Duration - Up to 24 months
Participants are observed over time to monitor physical and psychological health without active intervention.
Periodic assessments as scheduled by the clinic
Trial Site Locations
Total: 2 locations
1
Centre d'expertise Poids, Image et Alimentation (CEPIA)
Québec, Canada
Not Yet Recruiting
2
IUCPQ
Québec, Canada
Actively Recruiting
Research Team
S
Sylvain Iceta, MD, PhD
P
Pelletier Melissa
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here